Figure 1From: Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection Dose-dependent protection by WNIG. Groups of 5-week old BALB/c mice were treated i.p. with IVIG-IL (0.5 or 0.25 mg/mouse) or with WNIG (0.01, 0.05, or 0.025 mg/mouse) 4 h after infection with 10 LD50 of WNV NY99. Mice were observed for mortality for 21 days. One group of infected mice received no treatment (control).Back to article page